Chemoinformaics analysis of p-Coumarylquinic acid
| Molecular Weight | 442.728 | nRot | 5 |
| Heavy Atom Molecular Weight | 392.328 | nRig | 24 |
| Exact Molecular Weight | 442.381 | nRing | 5 |
| Solubility: LogS | -2.237 | nHRing | 0 |
| Solubility: LogP | 1.652 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 85.0436 |
| nHD | 2 | BPOL | 50.1604 |
| QED | 0.221 |
| Synth | 5.801 |
| Natural Product Likeliness | 1.845 |
| NR-PPAR-gamma | 0.047 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.052 |
| HIA | 0.778 |
| CACO-2 | -5.486 |
| MDCK | 0.000126607 |
| BBB | 0.166 |
| PPB | 0.288807 |
| VDSS | 0.826 |
| FU | 0.612515 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.068 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.571 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.065 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.162 |
| CYP3a4-inh | 0.035 |
| CYP3a4-sub | 0.415 |
| CL | 2.077 |
| T12 | 0.103 |
| hERG | 0.012 |
| Ames | 0.04 |
| ROA | 0.829 |
| SkinSen | 0.031 |
| Carcinogencity | 0.949 |
| EI | 0.007 |
| Respiratory | 0.85 |
| NR-Aromatase | 0.451 |
| Antiviral | No |
| Prediction | 0.727541 |